GlaxoSmithKline ($GSK) is weighing final offers for the portfolio of over-the-counter products it has put on the block, sources tell Reuters. The two front-runners in the second round of bidding are Bain Capital and a partnership between Blackstone and Prestige Brands, the sources said. Report